Börse:
4,713€
-2,43%
Echtzeit-Aktienkurs Aldeyra Therapeutics
Bid:
4,632€
Ask:
4,794€
| Allgemeine Informationen | ||
|---|---|---|
| Börsenwert: | 123,67 Mio. EUR (26,24 Mio. x 4,713€) | |
| Website: | - | |
| Sektor: | Medizin / Biotechnologie | |
| News-Radar | |
|---|---|
| dpa-AFX Pro - | Newsbot - |
| dpa-AFX - | Reuters - |
| 2015 | 2016 | 2017 | 2018 | |
|---|---|---|---|---|
| KUV | - | - | - | - |
| KGV | - | - | - | - |
| Div. Rend. | - | - | - | - |
Echtzeit-Chart der Aldeyra Therapeutics Aktie
Börsenkurse Aldeyra Therapeutics
| Dollar Indikation | 5,199$ | 0 | 5,381$ | 0 | 5,290$ | -2,22% |
| Euro Indikation | 4,632€ | 0 | 4,794€ | 0 | 4,713€ | -2,43% |
| Börse Stuttgart | 4,632€ | 0 | 4,794€ | 0 | 4,713€ | -0,90% |
Fundamentaldaten der Aldeyra Therapeutics Aktie
Aktuelle Geschäftsentwicklung
Sie benötigen die TraderFox Börsensoftware, um die aktuelle Geschäftsentwicklung einsehen zu können.
Income Statement: 10-Year-Summary
| Datum | Umsatz | EBIT | Gewinn | EPS | Dividende | KGV | KUV |
|---|---|---|---|---|---|---|---|
| 2018 | 0,00 Mio. | -38,89 Mio. | -38,89 Mio. | -1,79 | 0,00% | - | - |
| 2017 | 0,00 Mio. | -22,34 Mio. | -22,34 Mio. | -1,40 | 0,00% | - | - |
| 2016 | 0,00 Mio. | -18,70 Mio. | -18,70 Mio. | -1,65 | 0,00% | - | - |
| 2015 | 0,00 Mio. | -12,09 Mio. | -12,09 Mio. | -1,40 | 0,00% | - | - |
| 2014 | 0,00 Mio. | -5,19 Mio. | -5,19 Mio. | -2,49 | 0,00% | - | - |
Profil der Aldeyra Therapeutics Aktie
Aldeyra Therapeutics, Inc. operates as a biotechnology company. It primarily focuses on the development of new products for immune-mediated, inflammatory, orphan and other diseases that are thought to be caused in part by naturally occurring toxic chemical species known as free aldehydes. The company was founded by Thomas A. Jordan and John E. Dowling on August 13, 2004 and is headquartered in Lexington, MA.
TraderFox GmbH:
Impressum & Datenschutz -
Allgemeine Geschäftsbedingungen